389 related articles for article (PubMed ID: 14709855)
1. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Miyakoshi M; Kamoi K; Uchida S; Sasaki S
Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
[TBL] [Abstract][Full Text] [Related]
2. Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations.
Yoo TH; Ryu DR; Song YS; Lee SC; Kim HJ; Kim JS; Choi HY; Kang SW
Yonsei Med J; 2006 Feb; 47(1):126-30. PubMed ID: 16502494
[TBL] [Abstract][Full Text] [Related]
3. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation.
Hochberg Z; Van Lieburg A; Even L; Brenner B; Lanir N; Van Oost BA; Knoers NV
J Clin Endocrinol Metab; 1997 Feb; 82(2):686-9. PubMed ID: 9024277
[TBL] [Abstract][Full Text] [Related]
4. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
[TBL] [Abstract][Full Text] [Related]
5. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
Brenner B; Seligsohn U; Hochberg Z
J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
[TBL] [Abstract][Full Text] [Related]
6. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene.
van Lieburg AF; Knoers VV; Mallmann R; Proesmans W; van den Heuvel LP; Monnens LA
Nephron; 1996; 72(4):544-6. PubMed ID: 8730418
[TBL] [Abstract][Full Text] [Related]
7. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
8. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
[TBL] [Abstract][Full Text] [Related]
10. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
11. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
Knoers NV; Deen PM
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
[TBL] [Abstract][Full Text] [Related]
15. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
Inaba S; Hatakeyama H; Taniguchi N; Miyamori I
J Clin Endocrinol Metab; 2001 Jan; 86(1):381-5. PubMed ID: 11232028
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response.
Canfield MC; Tamarappoo BK; Moses AM; Verkman AS; Holtzman EJ
Hum Mol Genet; 1997 Oct; 6(11):1865-71. PubMed ID: 9302264
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an aquaporin-2 water channel gene mutation causing partial nephrogenic diabetes insipidus in a Mexican family: evidence of increased frequency of the mutation in the town of origin.
Boccalandro C; De Mattia F; Guo DC; Xue L; Orlander P; King TM; Gupta P; Deen PM; Lavis VR; Milewicz DM
J Am Soc Nephrol; 2004 May; 15(5):1223-31. PubMed ID: 15100362
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
[TBL] [Abstract][Full Text] [Related]
19. A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree.
Guo WH; Li Q; Wei HY; Lu HY; Qu HQ; Zhu M
J Int Med Res; 2016 Oct; 44(5):1131-1137. PubMed ID: 27565746
[TBL] [Abstract][Full Text] [Related]
20. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
Devuyst O
Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
